CryoPort (NASDAQ:CYRX) Cut to Buy at BidaskClub
Shares of CryoPort stock opened at $17.92 on Tuesday. The company has a quick ratio of 11.52, a current ratio of 11.57 and a debt-to-equity ratio of 0.42. The company has a market cap of $538.98 million, a P/E ratio of -57.81 and a beta of 0.84. CryoPort has a 52 week low of $8.28 and a 52 week high of $18.99.
CryoPort (NASDAQ:CYRX) last announced its earnings results on Thursday, May 2nd. The consumer goods maker reported ($0.08) EPS for the quarter, meeting analysts’ consensus estimates of ($0.08). The company had revenue of $6.65 million during the quarter, compared to the consensus estimate of $6.56 million. CryoPort had a negative return on equity of 28.30% and a negative net margin of 41.61%. The firm’s revenue for the quarter was up 65.4% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.10) earnings per share. On average, equities analysts predict that CryoPort will post -0.29 earnings per share for the current fiscal year.
A number of hedge funds have recently modified their holdings of CYRX. FMR LLC purchased a new stake in CryoPort in the fourth quarter worth $4,556,000. Essex Investment Management Co. LLC purchased a new stake in CryoPort in the fourth quarter worth $2,339,000. Pier Capital LLC grew its stake in CryoPort by 48.6% in the first quarter. Pier Capital LLC now owns 505,334 shares of the consumer goods maker’s stock worth $6,529,000 after purchasing an additional 165,229 shares during the period. BlackRock Inc. grew its stake in CryoPort by 8.9% in the first quarter. BlackRock Inc. now owns 1,913,047 shares of the consumer goods maker’s stock worth $24,717,000 after purchasing an additional 156,881 shares during the period. Finally, Roubaix Capital LLC purchased a new stake in CryoPort in the first quarter worth $1,679,000. 53.20% of the stock is currently owned by institutional investors.
CryoPort Company Profile
CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.
Recommended Story: Average Daily Trade Volume – What You Need to Know
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.